Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis

Remyelination requires innate immune system function, but how exactly microglia and macrophages clear myelin debris after injury and tailor a specific regenerative response is unclear. Here, we asked whether pro-inflammatory microglial/macrophage activation is required for this process. We establish...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of experimental medicine 2020-05, Vol.217 (5)
Hauptverfasser: Cunha, Maria Inês, Su, Minhui, Cantuti-Castelvetri, Ludovico, Müller, Stephan A, Schifferer, Martina, Djannatian, Minou, Alexopoulos, Ioannis, van der Meer, Franziska, Winkler, Anne, van Ham, Tjakko J, Schmid, Bettina, Lichtenthaler, Stefan F, Stadelmann, Christine, Simons, Mikael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page
container_title The Journal of experimental medicine
container_volume 217
creator Cunha, Maria Inês
Su, Minhui
Cantuti-Castelvetri, Ludovico
Müller, Stephan A
Schifferer, Martina
Djannatian, Minou
Alexopoulos, Ioannis
van der Meer, Franziska
Winkler, Anne
van Ham, Tjakko J
Schmid, Bettina
Lichtenthaler, Stefan F
Stadelmann, Christine
Simons, Mikael
description Remyelination requires innate immune system function, but how exactly microglia and macrophages clear myelin debris after injury and tailor a specific regenerative response is unclear. Here, we asked whether pro-inflammatory microglial/macrophage activation is required for this process. We established a novel toxin-based spinal cord model of de- and remyelination in zebrafish and showed that pro-inflammatory NF-κB-dependent activation in phagocytes occurs rapidly after myelin injury. We found that the pro-inflammatory response depends on myeloid differentiation primary response 88 (MyD88). MyD88-deficient mice and zebrafish were not only impaired in the degradation of myelin debris, but also in initiating the generation of new oligodendrocytes for myelin repair. We identified reduced generation of TNF-α in lesions of MyD88-deficient animals, a pro-inflammatory molecule that was able to induce the generation of new premyelinating oligodendrocytes. Our study shows that pro-inflammatory phagocytic signaling is required for myelin debris degradation, for inflammation resolution, and for initiating the generation of new oligodendrocytes.
doi_str_mv 10.1084/jem.20191390
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7201919</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2400546151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-3dc2a9e7f37edbdb569c0ac5415d21478ed2f8c0bd289c178b45e345b3fc5c563</originalsourceid><addsrcrecordid>eNpVkU1P3DAQhq0KVJZtb5yrHDk0MP5KnEsltKIFCakc2rPl2JOtwbHBzoL235N2F0RPI808emc0DyEnFM4oKHF-h-MZA9pR3sEHsqBSQN1Jrg7IAoCxmgK0R-S4lDsAKoRsPpIjzqBVTasW5P42p9rHIZhxNFPK28rYyT-ZyadYDSmE9OzjunI4bjH4uOv7UmV83PiMbmZytZtVNqDJJlqsTHRVCn6dHEaX0xojFl8-kcPBhIKf93VJfn-__LW6qm9-_rheXdzUlisx1dxZZjpsB96i610vm86CsVJQ6RgVrULHBmWhd0x1lraqFxK5kD0frLSy4UvybZf7sOlHdBbjlE3QD9mPJm91Ml7_P4n-j16nJ93--2M3B5zuA3J63GCZ9OiLxRBMxLQpmgkAKRoq6Yx-3aE2p1IyDm9rKOi_fvTsR7_6mfEv7097g1-F8Be20ZAu</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2400546151</pqid></control><display><type>article</type><title>Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Cunha, Maria Inês ; Su, Minhui ; Cantuti-Castelvetri, Ludovico ; Müller, Stephan A ; Schifferer, Martina ; Djannatian, Minou ; Alexopoulos, Ioannis ; van der Meer, Franziska ; Winkler, Anne ; van Ham, Tjakko J ; Schmid, Bettina ; Lichtenthaler, Stefan F ; Stadelmann, Christine ; Simons, Mikael</creator><creatorcontrib>Cunha, Maria Inês ; Su, Minhui ; Cantuti-Castelvetri, Ludovico ; Müller, Stephan A ; Schifferer, Martina ; Djannatian, Minou ; Alexopoulos, Ioannis ; van der Meer, Franziska ; Winkler, Anne ; van Ham, Tjakko J ; Schmid, Bettina ; Lichtenthaler, Stefan F ; Stadelmann, Christine ; Simons, Mikael</creatorcontrib><description>Remyelination requires innate immune system function, but how exactly microglia and macrophages clear myelin debris after injury and tailor a specific regenerative response is unclear. Here, we asked whether pro-inflammatory microglial/macrophage activation is required for this process. We established a novel toxin-based spinal cord model of de- and remyelination in zebrafish and showed that pro-inflammatory NF-κB-dependent activation in phagocytes occurs rapidly after myelin injury. We found that the pro-inflammatory response depends on myeloid differentiation primary response 88 (MyD88). MyD88-deficient mice and zebrafish were not only impaired in the degradation of myelin debris, but also in initiating the generation of new oligodendrocytes for myelin repair. We identified reduced generation of TNF-α in lesions of MyD88-deficient animals, a pro-inflammatory molecule that was able to induce the generation of new premyelinating oligodendrocytes. Our study shows that pro-inflammatory phagocytic signaling is required for myelin debris degradation, for inflammation resolution, and for initiating the generation of new oligodendrocytes.</description><identifier>ISSN: 0022-1007</identifier><identifier>EISSN: 1540-9538</identifier><identifier>DOI: 10.1084/jem.20191390</identifier><identifier>PMID: 32078678</identifier><language>eng</language><publisher>United States: Rockefeller University Press</publisher><subject>Animals ; Axons - drug effects ; Axons - pathology ; Cells, Cultured ; Demyelinating Diseases - pathology ; Disease Models, Animal ; Inflammation - pathology ; Larva - drug effects ; Lysophosphatidylcholines - metabolism ; Mice ; Microglia - drug effects ; Microglia - metabolism ; Mutation - genetics ; Myelin Sheath - drug effects ; Myelin Sheath - metabolism ; Myelin Sheath - pathology ; Myeloid Differentiation Factor 88 - metabolism ; Neuroscience ; Oligodendroglia - drug effects ; Oligodendroglia - metabolism ; Oligodendroglia - pathology ; Phagocytes - drug effects ; Phagocytes - pathology ; Phagosomes - drug effects ; Phagosomes - metabolism ; Proteome - metabolism ; Remyelination - drug effects ; Spinal Cord - pathology ; Tumor Necrosis Factor-alpha - pharmacology ; Zebrafish</subject><ispartof>The Journal of experimental medicine, 2020-05, Vol.217 (5)</ispartof><rights>2020 Cunha et al.</rights><rights>2020 Cunha et al. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-3dc2a9e7f37edbdb569c0ac5415d21478ed2f8c0bd289c178b45e345b3fc5c563</citedby><cites>FETCH-LOGICAL-c384t-3dc2a9e7f37edbdb569c0ac5415d21478ed2f8c0bd289c178b45e345b3fc5c563</cites><orcidid>0000-0001-5329-192X ; 0000-0001-5803-6098 ; 0000-0003-3414-307X ; 0000-0002-2175-8713 ; 0000-0003-1766-5458</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32078678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cunha, Maria Inês</creatorcontrib><creatorcontrib>Su, Minhui</creatorcontrib><creatorcontrib>Cantuti-Castelvetri, Ludovico</creatorcontrib><creatorcontrib>Müller, Stephan A</creatorcontrib><creatorcontrib>Schifferer, Martina</creatorcontrib><creatorcontrib>Djannatian, Minou</creatorcontrib><creatorcontrib>Alexopoulos, Ioannis</creatorcontrib><creatorcontrib>van der Meer, Franziska</creatorcontrib><creatorcontrib>Winkler, Anne</creatorcontrib><creatorcontrib>van Ham, Tjakko J</creatorcontrib><creatorcontrib>Schmid, Bettina</creatorcontrib><creatorcontrib>Lichtenthaler, Stefan F</creatorcontrib><creatorcontrib>Stadelmann, Christine</creatorcontrib><creatorcontrib>Simons, Mikael</creatorcontrib><title>Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis</title><title>The Journal of experimental medicine</title><addtitle>J Exp Med</addtitle><description>Remyelination requires innate immune system function, but how exactly microglia and macrophages clear myelin debris after injury and tailor a specific regenerative response is unclear. Here, we asked whether pro-inflammatory microglial/macrophage activation is required for this process. We established a novel toxin-based spinal cord model of de- and remyelination in zebrafish and showed that pro-inflammatory NF-κB-dependent activation in phagocytes occurs rapidly after myelin injury. We found that the pro-inflammatory response depends on myeloid differentiation primary response 88 (MyD88). MyD88-deficient mice and zebrafish were not only impaired in the degradation of myelin debris, but also in initiating the generation of new oligodendrocytes for myelin repair. We identified reduced generation of TNF-α in lesions of MyD88-deficient animals, a pro-inflammatory molecule that was able to induce the generation of new premyelinating oligodendrocytes. Our study shows that pro-inflammatory phagocytic signaling is required for myelin debris degradation, for inflammation resolution, and for initiating the generation of new oligodendrocytes.</description><subject>Animals</subject><subject>Axons - drug effects</subject><subject>Axons - pathology</subject><subject>Cells, Cultured</subject><subject>Demyelinating Diseases - pathology</subject><subject>Disease Models, Animal</subject><subject>Inflammation - pathology</subject><subject>Larva - drug effects</subject><subject>Lysophosphatidylcholines - metabolism</subject><subject>Mice</subject><subject>Microglia - drug effects</subject><subject>Microglia - metabolism</subject><subject>Mutation - genetics</subject><subject>Myelin Sheath - drug effects</subject><subject>Myelin Sheath - metabolism</subject><subject>Myelin Sheath - pathology</subject><subject>Myeloid Differentiation Factor 88 - metabolism</subject><subject>Neuroscience</subject><subject>Oligodendroglia - drug effects</subject><subject>Oligodendroglia - metabolism</subject><subject>Oligodendroglia - pathology</subject><subject>Phagocytes - drug effects</subject><subject>Phagocytes - pathology</subject><subject>Phagosomes - drug effects</subject><subject>Phagosomes - metabolism</subject><subject>Proteome - metabolism</subject><subject>Remyelination - drug effects</subject><subject>Spinal Cord - pathology</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>Zebrafish</subject><issn>0022-1007</issn><issn>1540-9538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU1P3DAQhq0KVJZtb5yrHDk0MP5KnEsltKIFCakc2rPl2JOtwbHBzoL235N2F0RPI808emc0DyEnFM4oKHF-h-MZA9pR3sEHsqBSQN1Jrg7IAoCxmgK0R-S4lDsAKoRsPpIjzqBVTasW5P42p9rHIZhxNFPK28rYyT-ZyadYDSmE9OzjunI4bjH4uOv7UmV83PiMbmZytZtVNqDJJlqsTHRVCn6dHEaX0xojFl8-kcPBhIKf93VJfn-__LW6qm9-_rheXdzUlisx1dxZZjpsB96i610vm86CsVJQ6RgVrULHBmWhd0x1lraqFxK5kD0frLSy4UvybZf7sOlHdBbjlE3QD9mPJm91Ml7_P4n-j16nJ93--2M3B5zuA3J63GCZ9OiLxRBMxLQpmgkAKRoq6Yx-3aE2p1IyDm9rKOi_fvTsR7_6mfEv7097g1-F8Be20ZAu</recordid><startdate>20200504</startdate><enddate>20200504</enddate><creator>Cunha, Maria Inês</creator><creator>Su, Minhui</creator><creator>Cantuti-Castelvetri, Ludovico</creator><creator>Müller, Stephan A</creator><creator>Schifferer, Martina</creator><creator>Djannatian, Minou</creator><creator>Alexopoulos, Ioannis</creator><creator>van der Meer, Franziska</creator><creator>Winkler, Anne</creator><creator>van Ham, Tjakko J</creator><creator>Schmid, Bettina</creator><creator>Lichtenthaler, Stefan F</creator><creator>Stadelmann, Christine</creator><creator>Simons, Mikael</creator><general>Rockefeller University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5329-192X</orcidid><orcidid>https://orcid.org/0000-0001-5803-6098</orcidid><orcidid>https://orcid.org/0000-0003-3414-307X</orcidid><orcidid>https://orcid.org/0000-0002-2175-8713</orcidid><orcidid>https://orcid.org/0000-0003-1766-5458</orcidid></search><sort><creationdate>20200504</creationdate><title>Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis</title><author>Cunha, Maria Inês ; Su, Minhui ; Cantuti-Castelvetri, Ludovico ; Müller, Stephan A ; Schifferer, Martina ; Djannatian, Minou ; Alexopoulos, Ioannis ; van der Meer, Franziska ; Winkler, Anne ; van Ham, Tjakko J ; Schmid, Bettina ; Lichtenthaler, Stefan F ; Stadelmann, Christine ; Simons, Mikael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-3dc2a9e7f37edbdb569c0ac5415d21478ed2f8c0bd289c178b45e345b3fc5c563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Axons - drug effects</topic><topic>Axons - pathology</topic><topic>Cells, Cultured</topic><topic>Demyelinating Diseases - pathology</topic><topic>Disease Models, Animal</topic><topic>Inflammation - pathology</topic><topic>Larva - drug effects</topic><topic>Lysophosphatidylcholines - metabolism</topic><topic>Mice</topic><topic>Microglia - drug effects</topic><topic>Microglia - metabolism</topic><topic>Mutation - genetics</topic><topic>Myelin Sheath - drug effects</topic><topic>Myelin Sheath - metabolism</topic><topic>Myelin Sheath - pathology</topic><topic>Myeloid Differentiation Factor 88 - metabolism</topic><topic>Neuroscience</topic><topic>Oligodendroglia - drug effects</topic><topic>Oligodendroglia - metabolism</topic><topic>Oligodendroglia - pathology</topic><topic>Phagocytes - drug effects</topic><topic>Phagocytes - pathology</topic><topic>Phagosomes - drug effects</topic><topic>Phagosomes - metabolism</topic><topic>Proteome - metabolism</topic><topic>Remyelination - drug effects</topic><topic>Spinal Cord - pathology</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>Zebrafish</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cunha, Maria Inês</creatorcontrib><creatorcontrib>Su, Minhui</creatorcontrib><creatorcontrib>Cantuti-Castelvetri, Ludovico</creatorcontrib><creatorcontrib>Müller, Stephan A</creatorcontrib><creatorcontrib>Schifferer, Martina</creatorcontrib><creatorcontrib>Djannatian, Minou</creatorcontrib><creatorcontrib>Alexopoulos, Ioannis</creatorcontrib><creatorcontrib>van der Meer, Franziska</creatorcontrib><creatorcontrib>Winkler, Anne</creatorcontrib><creatorcontrib>van Ham, Tjakko J</creatorcontrib><creatorcontrib>Schmid, Bettina</creatorcontrib><creatorcontrib>Lichtenthaler, Stefan F</creatorcontrib><creatorcontrib>Stadelmann, Christine</creatorcontrib><creatorcontrib>Simons, Mikael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cunha, Maria Inês</au><au>Su, Minhui</au><au>Cantuti-Castelvetri, Ludovico</au><au>Müller, Stephan A</au><au>Schifferer, Martina</au><au>Djannatian, Minou</au><au>Alexopoulos, Ioannis</au><au>van der Meer, Franziska</au><au>Winkler, Anne</au><au>van Ham, Tjakko J</au><au>Schmid, Bettina</au><au>Lichtenthaler, Stefan F</au><au>Stadelmann, Christine</au><au>Simons, Mikael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis</atitle><jtitle>The Journal of experimental medicine</jtitle><addtitle>J Exp Med</addtitle><date>2020-05-04</date><risdate>2020</risdate><volume>217</volume><issue>5</issue><issn>0022-1007</issn><eissn>1540-9538</eissn><abstract>Remyelination requires innate immune system function, but how exactly microglia and macrophages clear myelin debris after injury and tailor a specific regenerative response is unclear. Here, we asked whether pro-inflammatory microglial/macrophage activation is required for this process. We established a novel toxin-based spinal cord model of de- and remyelination in zebrafish and showed that pro-inflammatory NF-κB-dependent activation in phagocytes occurs rapidly after myelin injury. We found that the pro-inflammatory response depends on myeloid differentiation primary response 88 (MyD88). MyD88-deficient mice and zebrafish were not only impaired in the degradation of myelin debris, but also in initiating the generation of new oligodendrocytes for myelin repair. We identified reduced generation of TNF-α in lesions of MyD88-deficient animals, a pro-inflammatory molecule that was able to induce the generation of new premyelinating oligodendrocytes. Our study shows that pro-inflammatory phagocytic signaling is required for myelin debris degradation, for inflammation resolution, and for initiating the generation of new oligodendrocytes.</abstract><cop>United States</cop><pub>Rockefeller University Press</pub><pmid>32078678</pmid><doi>10.1084/jem.20191390</doi><orcidid>https://orcid.org/0000-0001-5329-192X</orcidid><orcidid>https://orcid.org/0000-0001-5803-6098</orcidid><orcidid>https://orcid.org/0000-0003-3414-307X</orcidid><orcidid>https://orcid.org/0000-0002-2175-8713</orcidid><orcidid>https://orcid.org/0000-0003-1766-5458</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1007
ispartof The Journal of experimental medicine, 2020-05, Vol.217 (5)
issn 0022-1007
1540-9538
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7201919
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Animals
Axons - drug effects
Axons - pathology
Cells, Cultured
Demyelinating Diseases - pathology
Disease Models, Animal
Inflammation - pathology
Larva - drug effects
Lysophosphatidylcholines - metabolism
Mice
Microglia - drug effects
Microglia - metabolism
Mutation - genetics
Myelin Sheath - drug effects
Myelin Sheath - metabolism
Myelin Sheath - pathology
Myeloid Differentiation Factor 88 - metabolism
Neuroscience
Oligodendroglia - drug effects
Oligodendroglia - metabolism
Oligodendroglia - pathology
Phagocytes - drug effects
Phagocytes - pathology
Phagosomes - drug effects
Phagosomes - metabolism
Proteome - metabolism
Remyelination - drug effects
Spinal Cord - pathology
Tumor Necrosis Factor-alpha - pharmacology
Zebrafish
title Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A55%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pro-inflammatory%20activation%20following%20demyelination%20is%20required%20for%20myelin%20clearance%20and%20oligodendrogenesis&rft.jtitle=The%20Journal%20of%20experimental%20medicine&rft.au=Cunha,%20Maria%20In%C3%AAs&rft.date=2020-05-04&rft.volume=217&rft.issue=5&rft.issn=0022-1007&rft.eissn=1540-9538&rft_id=info:doi/10.1084/jem.20191390&rft_dat=%3Cproquest_pubme%3E2400546151%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2400546151&rft_id=info:pmid/32078678&rfr_iscdi=true